Evolus, Inc. (EOLS) vs Evotec AG (EVO)
Evolus, Inc. and Evotec AG are both Drug Manufacturers Specialty & Generic companies. Evolus, Inc. and Evotec AG are of similar size ($539.9M and $519.2M). Evolus, Inc. grew revenue faster over the last twelve months: 13.9% against 2.15%. Evolus, Inc. has the higher net margin (−10.9% vs −26.2%) and the lower return on invested capital (−14.5% vs 0.00%). Across the 17 metrics below, Evolus, Inc. leads on 10 and Evotec AG on 7.
Valuation
Profitability
| Metric | EOLS | EVO | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 66.74% | 11.42% | 53.94% |
| Operating margin | (5.90%) | (21.35%) | 0.00% |
| Net margin | (10.85%) | (26.20%) | 0.00% |
| Free cash flow margin | (6.92%) | 0.00% | 0.00% |
| Return on equity | 138.57% | 0.00% | (0.40%) |
| Return on assets | (14.40%) | 0.00% | (3.32%) |
| Return on invested capital | (14.47%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack